Literature DB >> 25453015

Rhinocerebral mucormycosis in a diabetic case report.

Sm Oladeji, Yb Amusa, Jk Olabanji, Ao Adisa.   

Abstract

A 40 year old female Nigerian with uncontrolled diabetes mellitus was referred to a teaching hospital with four week history of facial rash that progressed to extensive ulceration of the mid face and bilateral visual loss. She had complete nasal bridge collapse, nasopalatal fistula with black eschars on the mucosa and markedly elevated fasting blood sugar. Her blood glucose was controlled on insulin, She had surgical debridement and histopathological study done revealed fungi hyphae. Systemic antifungal (ketoconazole) was given. Subsequently, she made a slow but steady progress and her wound became clean with healthy granulation tissue. Rhinocerebral mucormycosis still remains a poorly understood disease with high mortality rate. Presently, the triad of clinician's awareness, prompt initiation of treatment and timely surgical intervention represent the effective way of managing the disease.

Entities:  

Keywords:  Rhinocerebral mucormycosis; Uncontrolled diabetic

Year:  2013        PMID: 25453015      PMCID: PMC4228808     

Source DB:  PubMed          Journal:  J West Afr Coll Surg        ISSN: 2276-6944


  20 in total

1.  Rhinocerebral mucormycosis causing basilar artery aneurysm with concomitant fungal colonic perforation in renal allograft recipient: a case report.

Authors:  Anand Sehgal; M Raghavendran; Devendra Kumar; Aneesh Srivastava; Deepak Dubey; Anant Kumar
Journal:  Transplantation       Date:  2004-09-27       Impact factor: 4.939

Review 2.  Disseminated rhinocerebral mucormycosis: a case report and review of the literature.

Authors:  Brian M O'Neill; Anthony S Alessi; Elsa B George; John Piro
Journal:  J Oral Maxillofac Surg       Date:  2006-02       Impact factor: 1.895

Review 3.  Rhinocerebral mucormycosis: an update.

Authors:  A Mallis; S N Mastronikolis; S S Naxakis; A T Papadas
Journal:  Eur Rev Med Pharmacol Sci       Date:  2010-11       Impact factor: 3.507

4.  Rhinocerebral mucormycosis: pathways of spread.

Authors:  Seid Mousa Sadr Hosseini; Peyman Borghei
Journal:  Eur Arch Otorhinolaryngol       Date:  2005-05-13       Impact factor: 2.503

Review 5.  Zygomycosis (mucormycosis): emerging clinical importance and new treatments.

Authors:  Richard N Greenberg; Lauren J Scott; Heather H Vaughn; Julie A Ribes
Journal:  Curr Opin Infect Dis       Date:  2004-12       Impact factor: 4.915

Review 6.  Survival factors in rhino-orbital-cerebral mucormycosis.

Authors:  R A Yohai; J D Bullock; A A Aziz; R J Markert
Journal:  Surv Ophthalmol       Date:  1994 Jul-Aug       Impact factor: 6.048

7.  Fatal strokes in patients with rhino-orbito-cerebral mucormycosis and associated vasculopathy.

Authors:  Peterus Thajeb; Teguh Thajeb; Daofu Dai
Journal:  Scand J Infect Dis       Date:  2004

Review 8.  Zygomycosis: conventional laboratory diagnosis.

Authors:  C Lass-Flörl
Journal:  Clin Microbiol Infect       Date:  2009-10       Impact factor: 8.067

9.  Importance of immediate surgical intervention and antifungal treatment for rhinocerebral mucormycosis: a case report.

Authors:  Jin-Geun Kim; Hye Jeong Park; Jung Hyun Park; Jiwoong Baek; Hyung Jun Kim; In-Ho Cha; Woong Nam
Journal:  J Korean Assoc Oral Maxillofac Surg       Date:  2013-10-22

10.  Combination polyene-caspofungin treatment of rhino-orbital-cerebral mucormycosis.

Authors:  Caitlin Reed; Richard Bryant; Ashraf S Ibrahim; John Edwards; Scott G Filler; Robert Goldberg; Brad Spellberg
Journal:  Clin Infect Dis       Date:  2008-08-01       Impact factor: 9.079

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.